CMIUX
Price
$15.70
Change
+$0.03 (+0.19%)
Updated
Aug 8 closing price
Net Assets
10.5B
FHJUX
Price
$44.40
Change
-$0.03 (-0.07%)
Updated
Aug 8 closing price
Net Assets
887.42M
Interact to see
Advertisement

CMIUX vs FHJUX

Header iconCMIUX vs FHJUX Comparison
Open Charts CMIUX vs FHJUXBanner chart's image
Six Circles Mgd Eq Port Intl Uncons
Price$15.70
Change+$0.03 (+0.19%)
VolumeN/A
Net Assets10.5B
Fidelity Advisor Europe A
Price$44.40
Change-$0.03 (-0.07%)
VolumeN/A
Net Assets887.42M
CMIUX vs FHJUX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
CMIUX vs. FHJUX commentary
Aug 10, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CMIUX is a Hold and FHJUX is a StrongBuy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
CMIUX has more cash in the bank: 10.5B vs. FHJUX (887M). CMIUX pays higher dividends than FHJUX: CMIUX (2.50) vs FHJUX (2.36). CMIUX was incepted earlier than FHJUX: CMIUX (6 years) vs FHJUX (11 years). FHJUX (0.92) is less costly to investors than CMIUX (0.30). FHJUX is a more actively managed with annual turnover of: 31.00 vs. CMIUX (26.38). CMIUX (0) and FHJUX (0) have matching initial minimum investment requirements. FHJUX annual gain was more profitable for investors over the last year : 24.05 vs. CMIUX (18.66). CMIUX return over 5 years is better than : 86.59 vs. FHJUX (29.52).
CMIUXFHJUXCMIUX / FHJUX
Total Expense Ratio0.100.9211%
Annual Report Gross Expense Ratio0.300.9233%
Fund Existence6 years11 years-
Gain YTD21.89427.95478%
Front LoadN/A6%-
Min. Initial Investment00-
Min. Initial Investment IRAN/AN/A-
Net Assets10.5B887M1,184%
Annual Yield % from dividends2.502.36106%
Returns for 1 year18.6624.0578%
Returns for 3 years55.8152.46106%
Returns for 5 years86.5929.52293%
Returns for 10 yearsN/A24.25-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
FCUV2.240.09
+4.36%
Focus Universal
MET76.292.47
+3.35%
MetLife
CDXS2.77-0.01
-0.36%
Codexis
ELVN17.69-0.21
-1.17%
Enliven Therapeutics